[Therapeutic trial with plasmaclar in arteriosclerotic patients and modification of their cholesterol rates].
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000378:metabolism; D002784:Cholesterol / Q000096:biosynthesis; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004952:Esters; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D013451:Sulfonic Acids / Q000378:metabolism / Q000627:therapeutic use*; D014971:Xanthinol Niacinate / Q000378:metabolism / Q000627:therapeutic use
D004952:Esters; D000960:Hypolipidemic Agents; D013451:Sulfonic Acids; D014971:Xanthinol Niacinate; D002784:Cholesterol
Ensayo terapéutico con plasmaclar en enfermos arteriosclerosos y modificación de las tasas de colesterol en los mismos